The certification equips G42 Healthcare to support and drive clinical decisions as well as future development of tests using genomic, proteomic and clinical characteristics
G42 Healthcare plans to set up laboratory facilities in Abu Dhabi to provide Somascan proteomic services for research and clinical applications